Dr. Anthony Tjio, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 S Raymond Ave, Alhambra, CA 91801 Phone: 626-836-3020 Fax: 626-836-2920 |
Dr. Edward Hernandez, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 S Raymond Ave, Alhambra, CA 91801 Phone: 626-836-3020 Fax: 626-836-2920 |
Dr. Elmo Nazareno Orlino Sr., M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 S Raymond Ave, Alhambra, CA 91801 Phone: 626-458-4792 |
Priscilla Chao, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 S Raymond Ave, Alhambra, CA 91801 Phone: 626-570-1606 |
Laith Tawfeeq Alreshaid, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 S Fremont Ave Bldg A9, Office Of Revenue Cycle Management Provider Enrollmen, Alhambra, CA 91803 Phone: 626-457-5848 Fax: 626-457-4125 |
Dr. Andrew Shen, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 100 S Raymond Ave, Alhambra, CA 91801 Phone: 626-836-3020 Fax: 626-836-2920 |
News Archive
Overwhelming evidence accumulated during almost 20 years of clinical experience has established the benefits of this drug, which blocks the harmful effects of angiotensin, a substance that causes blood vessels to narrow, said the study authors.
A program that will provide employees in Namibia who work at sea with information on HIV/AIDS and focus on antiretroviral treatment is in an advanced stage of development, the New Era/AllAfrica.com reports.
ACT Biotech Inc., a privately held biotechnology company developing a portfolio of oral kinase inhibitors as anti-cancer drugs, today announced the acceptance of the Investigational New Drug (IND) application for ACTB1003 by the US Food and Drug Administration (FDA). The company has now assembled a complete preclinical package, including manufacturing and toxicology studies, allowing ACTB1003 to enter a clinical trial.
Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, today announced Calypso's real-time tracking technology is included in 36 scientific presentations and posters at the 51st Annual Meeting of the American Society for Therapeutic Radiation Oncology (ASTRO), now underway at McCormick Place in Chicago.
› Verified 4 days ago